JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kern, H.
Right arrow Articles by Schlame, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kern, H.
Right arrow Articles by Schlame, M.
Anesth Analg 2000;91:528-532
© 2000 International Anesthesia Research Society


CARDIOVASCULAR ANESTHESIA

Heparin Induces Release of Phospholipase A2 into the Splanchnic Circulation

Hartmut Kern, MD*, Wolfram Johnen, MD*, Jan Braun, MD*, Bettina Frey*, Bernd Rüstow, PhD{dagger}, Wolfgang J. Kox, MD, PhD, FRCP*, and Michael Schlame, MD, PhD, DEAA*

Departments of *Anesthesiology and Intensive Care Medicine and {dagger}Neonatology, University Hospital Charité, Humboldt University, Berlin, Germany

Address correspondence and reprint requests to Michael Schlame, MD, PhD, DEAA, Department of Anesthesiology and Intensive Care Medicine, University Hospital Charité, 10117 Berlin, Germany, Schumannstr. 20/21. Address e-mail to schlamem{at}hss.edu

Cardiopulmonary bypass results in increased plasma activity of phospholipase A2 (PLA2) that appears to be caused by the administration of heparin. High PLA2 activity may be responsible for increased production of eicosanoids and, thus, may be implicated in various pathophysiologic events associated with cardiac surgery. To investigate the site of PLA2 secretion, blood samples were simultaneously collected from the radial artery, the pulmonary artery, and the hepatic vein at 2, 4, 6, and 20 min after systemic heparinization (350 U/kg). Within 2 min of the heparin injection, plasma activity of PLA2 increased 4- to 9-fold and remained so for at least 20 min. Two minutes after the heparin injection, PLA2 was significantly higher in the hepatic vein than in the radial artery (P < 0.01). No such difference was detected between pulmonary and radial arteries. When heparin was added to blood samples in vitro (5–100 U/mL), plasma activity of PLA2 did not increase, which suggests that the enzyme was not secreted by blood cells.

Implications: Heparin, given in the dosage required for cardiopulmonary bypass, caused release of phospholipase A2 into the splanchnic circulation.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
R. de Vroege, W. van Oeveren, J. van Klarenbosch, W. Stooker, M. A. J. M. Huybregts, C. E. Hack, L. van Barneveld, L. Eijsman, and C. R. H. Wildevuur
The Impact of Heparin-Coated Cardiopulmonary Bypass Circuits on Pulmonary Function and the Release of Inflammatory Mediators
Anesth. Analg., June 1, 2004; 98(6): 1586 - 1594.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2000 by the International Anesthesia Research Society.